WordNet

an acute and serious infection of the central nervous system caused by bacterial infection of open wounds; spasms of the jaw and laryngeal muscles may occur during the late stages (同)lockjaw
a sustained muscular contraction resulting from a rapid series of nerve impulses
immunogen consisting of a suspension of weakened or dead pathogenic cells injected in order to stimulate the production of antibodies (同)vaccinum
acute contagious infection caused by the bacterium Corynebacterium diphtheriae; marked by the formation of a false membrane in the throat and other air passages causing difficulty in breathing

PrepTutorEJDIC

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 0～6歳の乳児および小児におけるジフテリア、破傷風、および百日咳ワクチン diphtheria tetanus and pertussis immunization in infants and children 0 through 6 years of age
2. 思春期および成人における百日咳菌感染症の治療および予防 treatment and prevention of bordetella pertussis infection in adolescents and adults
3. 7～18歳の小児におけるジフテリア、破傷風、および百日咳ワクチン diphtheria tetanus and pertussis immunization in children 7 through 18 years of age
4. 破傷風 tetanus
5. 幼児および小児における百日咳菌感染症の治療および予防 treatment and prevention of bordetella pertussis infection in infants and children

Immunogenicity, safety, and antibody persistence at 3, 5, and 10 years postvaccination in adolescents randomized to booster immunization with a combined tetanus, diphtheria, 5-component acellular pertussis, and inactivated poliomyelitis vaccine administered with a hepatitis B virus vaccine concurrently or 1 month apart.

Embree J1, Law B1, Voloshen T2, Tomovici A3.
Clinical and vaccine immunology : CVI.Clin Vaccine Immunol.2015 Mar;22(3):282-90. doi: 10.1128/CVI.00682-14. Epub 2014 Dec 24.
An understanding of the antibody persistence elicited by a combined tetanus, diphtheria, 5-component acellular pertussis, and inactivated poliovirus vaccine (Tdap-IPV) after adolescent vaccination is important to optimize booster dosing intervals. Our objectives were to compare the safety and immuno
PMID 25540274

Mixing of diphtheria, tetanus and acellular pertussis (DTaP) vaccines in a population of children in managed care.

Masseria C1, Buikema AR, Liu F, Krishnarajah G.
Human vaccines & immunotherapeutics.Hum Vaccin Immunother.2015 Feb 25:0. [Epub ahead of print]
The Advisory Committee on Immunization Practices recommends administering diphtheria, tetanus and acellular pertussis (DTaP) vaccines to children at 2, 4, 6, 15-18 months, and 4-6 years of age; preferably with the same-brand vaccine for the whole series. We estimated age-appropriate DTaP dose compl
PMID 25714800

Is there an association between the coverage of immunisation boosters by the age of 5 and deprivation? An ecological study.

Sandford H1, Tata LJ2, Browne I3, Pritchard C4.
Vaccine.Vaccine.2015 Feb 25;33(9):1218-22. doi: 10.1016/j.vaccine.2014.12.006. Epub 2014 Dec 16.
OBJECTIVE: To determine whether there was an association between the coverage of booster immunisation of Diphtheria, Tetanus, acellular Pertussis and Polio (DTaP/IPV) and second Measles, Mumps and Rubella (MMR) dose by age 5 in accordance with the English national immunisation schedule by area-level
PMID 25527213

Collaborative Study: Standardization of Japanese Reference Diphtheria and Tetanus Toxoids, (Adsorbed, Lot2), for Potency Determination of Diphtheria-Tetanus-Acellular Pertussis Combined Vaccine